[HTML][HTML] Sunitinib resistance in renal cell carcinoma: From molecular mechanisms to predictive biomarkers

J Jin, Y Xie, JS Zhang, JQ Wang, SJ Dai, W He… - Drug Resistance …, 2023 - Elsevier
Currently, renal cell carcinoma (RCC) is the most prevalent type of kidney cancer. Targeted
therapy has replaced radiation therapy and chemotherapy as the main treatment option for …

Involvement of actin and actin-binding proteins in carcinogenesis

M Izdebska, W Zielińska, M Hałas-Wiśniewska… - Cells, 2020 - mdpi.com
The actin cytoskeleton plays a crucial role in many cellular processes while its
reorganization is important in maintaining cell homeostasis. However, in the case of cancer …

Heterogenous presence of neutrophil extracellular traps in human solid tumours is partially dependent on IL‐8

CE de Andrea, MC Ochoa… - The Journal of …, 2021 - Wiley Online Library
Neutrophil extracellular traps (NETs) are webs of extracellular nuclear DNA extruded by
dying neutrophils infiltrating tissue. NETs constitute a defence mechanism to entrap and kill …

Activation of PI3K/AKT pathway is a potential mechanism of treatment resistance in small cell lung cancer

Y Jin, Y Chen, H Tang, X Hu, SM Hubert, Q Li… - Clinical Cancer …, 2022 - AACR
Purpose: Here, we have investigated treatment resistance mechanisms in small cell lung
cancer (SCLC) by focusing on comparing the genotype and phenotype in tumor samples of …

[HTML][HTML] Histone methyltransferase SETD2: a potential tumor suppressor in solid cancers

R Chen, W Zhao, C Fang, X Yang, M Ji - Journal of Cancer, 2020 - ncbi.nlm.nih.gov
Epigenetic regulation plays an important role in the occurrence, development and treatment
of malignant tumors; and a great deal of attention has been paid to the histone methylation …

Epigenetic enzyme mutations as mediators of anti-cancer drug resistance

S Chen, Y Zhao, S Liu, J Zhang, YG Assaraf… - Drug Resistance …, 2022 - Elsevier
Despite the rapid advancement in the introduction of new drugs for cancer therapy, the
frequent emergence of drug resistance leads to disease progression or tumor recurrence …

Hispidulin: A promising flavonoid with diverse anti-cancer properties

K Liu, F Zhao, J Yan, Z Xia, D Jiang, P Ma - Life Sciences, 2020 - Elsevier
In recent years, natural products have increasingly attracted more attention because of their
potential anticancer activity and low intrinsic toxicity. Hispidulin is a natural flavonoid with a …

LRP1B: a giant lost in cancer translation

C Príncipe, IJ Dionísio de Sousa, H Prazeres… - Pharmaceuticals, 2021 - mdpi.com
Low-density lipoprotein receptor-related protein 1B (LRP1B) is a giant member of the LDLR
protein family, which includes several structurally homologous cell surface receptors with a …

A role for SETD2 loss in tumorigenesis through DNA methylation dysregulation

H Javaid, A Barberis, O Chervova, I Nassiri, V Voloshin… - BMC cancer, 2023 - Springer
Abstract SETD2-dependent H3 Lysine-36 trimethylation (H3K36me3) has been recently
linked to the deposition of de-novo DNA methylation. SETD2 is frequently mutated in cancer …

Histone methyltransferase and drug resistance in cancers

C Yang, J Zhang, Y Ma, C Wu, W Cui… - Journal of Experimental & …, 2020 - Springer
A number of novel anticancer drugs have been developed in recent years. However, the
mortality of cancer patients remains high because of the emergence of drug resistance. It …